US 11845787
DNA antibody constructs for use against HIV
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11845787 (DNA antibody constructs for use against HIV) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/53, A61K2039/54